Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCARP-DIAL
2026-526075-35-00Phase 4Authorised
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin in cardiac morbidity, sponsored by Karolinska University Hospital. Primary endpoint: Time to first major adverse cardiovascular event. Planned start Sep 2026; status: authorised.
02
Drugs
dapagliflozin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2026-526075-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526075-35-00.